MyAverix Finance
PA · Healthcare
Gensight Biologics SA (SIGHT)
Biotechnology
Gensight Biologics SA (SIGHT) is listed on PA in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $20.63M, P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for SIGHT
Gensight Biologics SA (SIGHT) — FAQ
What is Gensight Biologics SA's market cap?
Gensight Biologics SA (SIGHT) has a reported market cap of $20.63M (data as of 2026-05-24).
What is SIGHT's P/E ratio?
The price-to-earnings (P/E) ratio for Gensight Biologics SA (SIGHT) is 25.00 (data as of 2026-05-24).
Does Gensight Biologics SA pay a dividend?
Dividend yield is not available in the current snapshot for Gensight Biologics SA (SIGHT). Check the MyAverix Finance app for the latest dividend data.
What sector is Gensight Biologics SA in?
Gensight Biologics SA (SIGHT) is classified in the Healthcare sector (Biotechnology industry).
What exchange is SIGHT listed on?
SIGHT is listed on PA.
What is Gensight Biologics SA's net margin?
Gensight Biologics SA (SIGHT) reports a net margin of 0.0% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.